Jim Fulton is a partner in the Emerging Companies practice group. He joined the Firm in 1995 and is resident in the New York office. Prior to his tenure in New York, Jim spent 17 years practicing in Cooley's Palo Alto office where he was firm-wide Chair of the Emerging Companies practice group and chair of the Clean Energy and Technologies group.

Jim focuses on representing both emerging and established technology, healthcare and biotechnology companies and the venture capital firms that invest in those companies. Concentrating in corporate and securities law, he counsels companies throughout their lifecycle on matters ranging from company formations, private financings, employee equity incentives and executive hiring, to complex spinouts, mergers and acquisitions, IPOs and SEC reporting and compliance. In the last 10 years alone, Jim has worked on more than 350 venture capital transactions, raising more than $4 billion dollars. In addition, Jim has closed venture capital funds raising in excess of $5 billion, public offerings of nearly $1 billion in equity and M&A transactions valued at more than $3 billion.